She was discharged on the seventh postoperative day, and follow-up at six months showed normalized tumor markers (CA-125 at 16.6 IU/mL and HE-4 at 30.7 pmol/L), with no evidence of recurrence or residual effusion on contrast enhanced-CT (Figures 4A–C). The gene discussed is WFDC2; the disease is neoplasm.